Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda

被引:57
作者
Brady, JJ
Jackson, HA
Roberts, AG
Morgan, RR
Whatley, SD
Rowlands, GL
Darby, C
Shudell, E
Watson, R
Paiker, J
Worwood, MW
Elder, GH
机构
[1] Univ Wales Hosp, Dept Med Biochem, Cardiff CF4 4XW, S Glam, Wales
[2] Univ Wales Hosp, Dept Haematol, Cardiff CF4 4XW, S Glam, Wales
[3] Univ Wales Coll Med, Cardiff CF4 4XN, S Glam, Wales
[4] St Jamess Hosp, Dept Biochem, Dublin, Ireland
[5] Our Ladys Hosp Sick Children, Dept Dermatol, Dublin, Ireland
[6] Univ Witwatersrand, S African Inst Med Res, Dept Chem Pathol, Johannesburg, South Africa
关键词
uroporphyrinogen decarboxylase; hemochromatosis;
D O I
10.1046/j.1523-1747.2000.00148.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Porphyria cutanea tarda is a skin disease caused by photosensitization by porphyrins whose accumulation is caused by deficiency of hepatic uroporphyrin- ogen decarboxylase activity. Mutations in the uroporphyrinogen decarboxylase gene are present in the low-penetrant, autosomal dominant familial form but not in the commoner sporadic form of porphyria cutanea tarda. We have investigated the relationship between age of onset of skin lesions and mutations (C282Y, H63D) in the hemochromatosis gene in familial (19 patients) and sporadic porphyria cutanea tarda (65 patients). Familial porphyria cutanea tarda was identified by mutational analysis of the uroporphyrinogen decarboxylase gene. Five previously described and eight novel mutations (A80S, R144P, L216Q, E218K, L282R, G303S, 402-403delGT, IVS2 + 2 delTAA) were identified. Homozygosity for the C282Y hemochromatosis mutation was associated with an earlier onset of skin lesions in both familial and sporadic porphyria cutanea tarda, the effect being more marked in familial porphyria cutanea tarda where anticipation was demonstrated in family studies. Analysis of the frequencies of hemochromatosis genotypes in each type of porphyria cutanea tarda indicated that C282Y homozygosity is an important susceptibility factor in both types but suggested that heterozygosity for this mutation has much less effect on the development of the disease.
引用
收藏
页码:868 / 874
页数:7
相关论文
共 63 条
[1]   PORPHYRIA-CUTANEA-TARDA AND HLA-LINKED HEMOCHROMATOSIS - ALL IN THE FAMILY [J].
ADAMS, PC ;
POWELL, LW .
GASTROENTEROLOGY, 1987, 92 (06) :2033-2035
[2]   PREVALENCE OF ABNORMAL IRON STUDIES IN HETEROZYGOTES FOR HEREDITARY HEMOCHROMATOSIS - AN ANALYSIS OF 255 HETEROZYGOTES [J].
ADAMS, PC .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (02) :146-149
[3]   Haplotype analysis of hemochromatosis: Evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes [J].
Ajioka, RS ;
Jorde, LB ;
Gruen, JR ;
Yu, P ;
Dimitrova, D ;
Barrow, J ;
Radisky, E ;
Edwards, CQ ;
Griffen, LM ;
Kushner, JP .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (06) :1439-1447
[4]   Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America [J].
Bonkovsky, HL ;
Poh-Fitzpatrick, M ;
Pimstone, N ;
Obando, J ;
Di Bisceglie, A ;
Tattrie, C ;
Tortorelli, K ;
LeClair, P ;
Mercurio, MG ;
Lambrecht, RW .
HEPATOLOGY, 1998, 27 (06) :1661-1669
[5]   Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda [J].
Bulaj, ZJ ;
Phillips, JD ;
Ajioka, RS ;
Franklin, MR ;
Griffen, LM ;
Guinee, DJ ;
Edwards, CQ ;
Kushner, JP .
BLOOD, 2000, 95 (05) :1565-1571
[6]  
BULAZ ZJ, 1996, NEW ENGL J MED, V335, P1837
[7]  
Cardoso EMP, 1998, J INTERN MED, V243, P203
[8]  
Christiansen L, 1999, HUM MUTAT, V14, P222, DOI 10.1002/(SICI)1098-1004(1999)14:3<222::AID-HUMU5>3.0.CO
[9]  
2-V
[10]  
Christiansen L, 1999, CLIN CHEM, V45, P2025